Ovarian Cancer — Year in Review Series on Relevant New Datasets and Advances
Oncology Today with Dr Neil Love
00:00
Relacorilant plus nab‑paclitaxel (Rosella)
Kathleen explains relacorilant's glucocorticoid receptor antagonism, rationale for nab‑paclitaxel, and reported survival benefit.
Play episode from 33:31
Transcript
